merged_africa-snakebite-treatment-access.txt
<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>Venom variation across snake populations due to geographical separation makes antivenom specific to certain regions.</answer>
<question_number>3</question_number>
<answer>Neurotoxins and hemotoxins are major toxin families, and current antivenom is limited by specificity and allergic reactions.</answer>
<question_number>4</question_number>
<answer>Traditional healers may not recognize spitting cobra venom effects in the eye and misdiagnose it as a non-venomous ocular injury.</answer>
<question_number>5</question_number>
<answer>Rainy season flooding and hot, dry season search for food/water increase snake encounters near homes and farms, creating risk peaks for farmers and rural residents.</answer>
<question_number>6</question_number>
<answer>Short, erect fangs, neurotoxic venom, and aggressive/quick striking behavior.</answer>
<question_number>7</question_number>
<answer>Thermal instability requires cold storage, which is challenging with Kenya's infrastructure limitations, leading to delays and reduced antivenom effectiveness within the critical six-hour window, disproportionately affecting vulnerable groups.</answer>
<question_number>8</question_number>
<answer>Tourniquets intended to halt venom spread worsen local tissue damage and increase amputation risk, contradicting their intended benefit, especially with hospital delays.</answer>
<other>I have answered all eight questions based on the provided article and followed the requested format.</other>